Cipla moves up on launching authorized generic of Aloxi

26 Mar 2018 Evaluate

Cipla is currently trading at Rs. 538.20, up by 0.90 points or 0.17% from its previous closing of Rs. 537.30 on the BSE.

The scrip opened at Rs. 539.00 and has touched a high and low of Rs. 541.95 and Rs. 535.20 respectively. So far 1390 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 663.00 on 07-Nov-2017 and a 52 week low of Rs. 479.00 on 26-May-2017.

Last one week high and low of the scrip stood at Rs. 567.45 and Rs. 523.00 respectively. The current market cap of the company is Rs. 43259.05 crore.

The promoters holding in the company stood at 37.24%, while Institutions and Non-Institutions held 37.84% and 24.92% respectively.

Cipla USA, (Cipla) has launched an authorized generic version of Aloxi in the United States under applicable agreements with Helsinn Healthcare SA, in response to the at-risk launch by Teva.

Helsinn Healthcare SA currently manufactures and markets Aloxi in the United States through its licensee Eisai Inc. and its affiliate Helsinn Therapeutics (US) Inc. Aloxi containing palonosetron hydrochloride injections (Eq. 0.25 mg base/5 ml) is indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy and for prevention of acute nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy.

According to IMS Health, Aloxi brand had US sales of approximately $460 million for the 12-month period ending November 2017. Cipla’s Authorized Generic of Aloxi is available for shipping immediately.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×